The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
about
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The glutamate transport inhibi ...... stant colorectal cancer cells.
@ast
The glutamate transport inhibi ...... stant colorectal cancer cells.
@en
type
label
The glutamate transport inhibi ...... stant colorectal cancer cells.
@ast
The glutamate transport inhibi ...... stant colorectal cancer cells.
@en
prefLabel
The glutamate transport inhibi ...... stant colorectal cancer cells.
@ast
The glutamate transport inhibi ...... stant colorectal cancer cells.
@en
P2093
P2860
P50
P1433
P1476
The glutamate transport inhibi ...... istant colorectal cancer cells
@en
P2093
Anders A Jensen
Elena Pedraz-Cuesta
Maria Unni Romer
Niels Frank Jensen
Nils Brünner
Sandra Christensen
P2860
P2888
P356
10.1186/S12885-015-1405-8
P407
P577
2015-05-16T00:00:00Z
P5875
P6179
1013963982